ExamPassdump의 경험이 풍부한 IT전문가들이 연구제작해낸 Salesforce인증 ALS-Con-201덤프는 시험패스율이 100%에 가까워 시험의 첫번째 도전에서 한방에 시험패스하도록 도와드립니다. Salesforce인증 ALS-Con-201덤프는Salesforce인증 ALS-Con-201최신 실제시험문제의 모든 시험문제를 커버하고 있어 덤프에 있는 내용만 공부하시면 아무런 걱정없이 시험에 도전할수 있습니다.
| Certification Vendor: | Salesforce |
|---|---|
| Exam Name: | Salesforce Certified Agentforce Life Sciences Consultant |
| Exam Number: | ALS-Con-201 |
| Exam Price: | US$200 |
| Related Certifications: | Salesforce Certified Platform Administrator |
| Exam Duration: | 105 minutes |
| Real Exam Qty: | 60-65 |
| Exam Format: | Multiple-choice, Scenario-based |
| Certificate Validity Period: | 2 years |
| Available Languages: | English |
| Passing Score: | 62% |
| Recommended Training: | Agentforce Life Sciences Consultant Certification Preparation |
| Exam Registration: | Salesforce Certification Registration |
| Sample Questions: | Salesforce ALS-Con-201 Sample Questions |
| Exam Way: | Online proctored or onsite testing center |
| Pre Condition: | Hold Salesforce Certified Platform Administrator certification; at least 1 year experience in life sciences industry; at least 6 months hands-on experience configuring Agentforce Life Sciences |
| Official Syllabus URL: | https://help.salesforce.com/s/articleView?id=005305357&language=en_US |
여러분은Salesforce ALS-Con-201인증시험을 패스함으로 IT업계관련 직업을 찿고자하는 분들에게는 아주 큰 가산점이 될수 있으며, 성덩한 IT업계사업자와 한걸음 가까와 집니다.
| 주제 | 소개 |
|---|---|
| 주제 1 |
|
| 주제 2 |
|
| 주제 3 |
|
| 주제 4 |
|
질문 # 66
Choose 1 option.
Cumulus Pharma is expanding its "Immunexis" sampling program to Germany. The local compliance officer advises that Germany has strict, non-negotiable statutory limits on sample quantities that must be applied to all Healthcare Providers (HCPs). The Agentforce Life Sciences solution must ensure strict adherence to German law without requiring the admin to manually maintain the complex rule logic.
Which solution meets this requirement?
정답：C
설명：
The correct answer is B because Salesforce Life Sciences Cloud for Customer Engagement includes country-specific sample limit templates by default. Salesforce Help states that Life Sciences Cloud includes a generic sample limit template and several country-specific templates by default. These templates are intended to support sample-limit compliance where rules vary by country, including situations where statutory limits must be consistently applied without requiring administrators to rebuild complex legal rules from scratch.
In this scenario, Germany has strict legal limits on sample quantities that must apply to all HCPs. A default country-specific template is the best fit because it is designed to represent country-level sample compliance requirements in a reusable configuration. This approach reduces administrative maintenance, improves consistency, and helps ensure the sampling program follows local legal constraints.
Option A is incorrect because adding a new sample limit to custom metadata would require the admin or implementation team to manually maintain rule logic, which the requirement explicitly wants to avoid. Option C is also not the best answer because manually creating a sample limit rule in the Admin Console may work for custom business policies, but it is less appropriate when Salesforce provides a default country-specific template for statutory country rules. Therefore, the consultant should use the Default Country-Specific Template for Germany.
=========
질문 # 67
Choose 1 option.
Cumulus Pharma wants to use Activity Plans to measure high-impact activities with specific Healthcare Providers (HCPs) who are aligned with the company's objectives and need to be measured differently.
Which Activity Plan configuration on the Provider Activity Goal Measure screen is critical to measure such high-impact activities?
정답：B
설명：
Option B is correct because Salesforce Life Sciences Activity Plans use weighted goals to measure activities differently based on business importance. Salesforce Help for creating Activity Plans states that, to track weighted goals, administrators create Provider Activity Goal Measure records to define weights, select Weighted Goal in the Type field, and assign a value in Activity Weight Value. This directly supports the requirement to measure high-impact activities differently from standard activities.
Activity Plans are designed to transform provider interaction strategies into actionable goals and targets for field representatives. When certain activities with specific HCPs are more strategically important, weighted goals allow those activities to contribute differently to plan performance. This is more precise than simply counting every activity equally.
Option A is incorrect because "High Impact Goal" is not the documented Type value for this configuration. The Salesforce Help wording identifies "Weighted Goal" as the Type value used for weighted measurement. Option C is also not correct because the documented field is Activity Weight Value, not Activity Impact. Even if a percentage-based concept sounds plausible, the standard configuration step is to set the Provider Activity Goal Measure Type to Weighted Goal and enter the weight value. Therefore, the consultant should select Weighted Goal for the Type field.
=========
질문 # 68
Choose 1 option.
A field sales rep attempts to add Immunexis to the Product Detailing section during a visit, but the product does not appear in the search results. The product record exists in Salesforce. The product must be explicitly enabled for use in visit discussions.
What should be configured in the Visit Administration tile on the Agentforce Life Sciences for Customer Engagement Admin Console?
정답：A
설명：
The correct answer is B because the product must be enabled for discussion in the visit-detailing experience. Salesforce's Life Sciences Visit Management developer documentation states that information entered in a provider visit typically includes product details, product messages, presentations, marketing items, and samples. Salesforce Trailhead also explains that Life Sciences Cloud uses product administration and product-message configuration to ensure reps only promote and discuss therapies within approved guardrails.
The scenario says the product exists in Salesforce, but it does not appear when the rep tries to add it to the Product Detailing section during a visit. That means the issue is not product creation; it is visit-discussion eligibility. The consultant should configure Product Discussion Settings in the Visit Administration area so Immunexis is available for product detailing and visit discussions.
Option A is incorrect because Territory Product Alignment Rules determine which products are aligned to territories, but the question specifically says the product must be explicitly enabled for use in visit discussions. Territory alignment alone does not guarantee the product appears in the Product Detailing search. Option C is also incorrect because Visit Record Type Mappings control record-type behavior, not whether a product can be discussed. Therefore, the correct configuration is Product Discussion Settings.
질문 # 69
Choose 1 option.
An Agentforce Life Sciences Consultant is asked to configure strategic distribution limits for Immunexis 50mg in a high-growth territory. The business requirement mandates that the total quantity available for the territory in the next quarter is capped, and individual field sales reps are restricted from handing off more than 50 units in a single visit.
Which administrative configuration should the consultant recommend?
정답：C
설명：
Option C is correct because Territory Product Quantity Allocations are designed to manage sample product distribution at the territory level. Salesforce Help explains that territory product quantity allocations and sample limits both help manage sample distribution to HCPs, but territory product quantity allocation is used when the business needs to allocate a defined product quantity to a territory. Salesforce's setup guidance for Territory Product Quantity Allocations also states that Max Disbursement Limit Quantity is the maximum amount a sales rep can disburse in a given visit.
This directly matches the requirement. Cumulus Pharma wants to cap the total quantity of Immunexis 50mg available for a high-growth territory in the next quarter and also prevent reps from handing off more than 50 units in a single visit. A Territory Product Quantity Allocation record can store the territory-level allocated quantity, while Max Disbursement Limit Quantity enforces the per-visit disbursement cap.
Option A is incorrect because an Advanced Sample Limit Template focuses on account or provider-level sample limits, not the total allocation available to a territory. Option B is also incorrect because changing the Life Sciences Marketable Product globally would affect the entire organization, not just the high-growth territory. Therefore, the correct recommendation is to create a Territory Product Quantity Allocation record and set the per-visit max disbursement limit to 50.
=========
질문 # 70
Choose 1 option.
Cumulus Pharma's field sales reps use the Medical Insights feature in Agentforce Life Sciences for Customer Engagement to record insights from their engagements with Healthcare Providers (HCPs). The VP of Customer Engagement wants the reps to provide feedback on the medical insights captured.
Which object should an Agentforce Life Sciences Consultant recommend?
정답：B
설명：
The correct answer is A because User Reaction is the object designed to capture user feedback or reactions related to a Medical Insight. Salesforce's Life Sciences Cloud Developer Guide identifies the UserReaction object and states that it can be associated with a medical insight through the source reference record relationship. This makes it the most appropriate object when users need to provide feedback on Medical Insights that have already been captured.
The scenario is not asking field reps to complete a formal assessment or collect HCP feedback. It asks for reps to provide feedback on the medical insights captured in the system. A User Reaction record supports this by allowing a user-level response to be connected back to the relevant Medical Insight record, preserving the relationship between the insight and the feedback.
Option B, Assessment Task, is incorrect because assessment tasks are typically used as structured tasks or questionnaires within planning, account management, or guided evaluation workflows. They are not the direct object for providing reactions to Medical Insights. Option C, Survey, is also incorrect because surveys are used to collect responses, often from customers or HCPs, through a survey experience. A survey would be unnecessary and less precise for internal rep feedback on an existing Medical Insight. Therefore, User Reaction is the correct object to recommend.
=========
질문 # 71
......
ALS-Con-201완벽한 시험기출자료: https://www.exampassdump.com/ALS-Con-201_valid-braindumps.html